Abstract
Correction for ‘PAMAM/5-fluorouracil drug conjugate for targeting E6 and E7 oncoproteins in cervical cancer: a combined experimental/in silico approach’ by Arunkumar Rengaraj et al., RSC Adv., 2017, 7, 5046-5054.
| Original language | English |
|---|---|
| Pages (from-to) | 11281 |
| Number of pages | 1 |
| Journal | RSC Advances |
| Volume | 7 |
| Issue number | 19 |
| DOIs |
|
| State | Published - 2017 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Correction: PAMAM/5-fluorouracil drug conjugate for targeting E6 and E7 oncoproteins in cervical cancer: a combined experimental/in silico approach (RSC Adv. (2017) 7 (5046-5054) DOI: 10.1039/C6RA26511A)'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver